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ABSTRACT 
Background:  Research findings are not rapidly or fully implemented into policies and 
practice in care.  
Objectives:  To assess whether an ‘active’ strategy was more likely to lead to changes 
in policy and practice in preterm babies care than traditional information dissemination. 
Design:  Cluster randomised trial.  
Participants: 180 neonatal units (87 active, 93 control) in England; clinicians from active 
arm units; babies born < 27 weeks gestation.  
Control arm: Dissemination of research report; slides; information about newborn care 
position statement.  
Active arm: As above plus offer to become ‘regional ‘champion’ (attend two workshops, 
support clinicians to implement research evidence regionally), or attend one workshop, 
promote implementation of research evidence locally.   
Main outcome measures – timing of surfactant administration; admission temperature; 
staffing of resuscitation team present at birth.   
Results:  48/87 Lead Clinicians in the active arm attended one or both workshops.  
There was no evidence of difference in post-intervention policies between trial arms.  
Practice outcomes based on babies in the active (169) and control arms (186), in 45 and 
49 neonatal units respectively, showed active arm babies were more likely to have been 
given surfactant on labour ward (RR=1.30; 95%CI 0.99 to1.70); p=0.06); to have a 
higher temperature on admission to NICU (mean difference=0.29oC; 95%CI 0.22 to 0.55; 
p=0.03); and to have had the baby’s trunk delivered into a plastic bag (RR=1.27; 95%CI 
1.01 to1.60; p=0.04) than the control group. The effect on having an ‘ideal’ resuscitation 
team at birth was in the same direction of benefit for the active arm (OR=1.18; 95%CI 
0.97 to1.43; p=0.09). The costs of the intervention were modest.  
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Conclusions:   This is the first trial to evaluate methods for transferring information from 
neonatal research into local policies and practice in England.  An active approach to 
research dissemination is both feasible and cost-effective.     
Source of funding: Bliss Innovation in Care Programme  
Trial registration: Current controlled trials ISRCTN89683698 
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INTRODUCTION 
The findings of health service research are frequently not implemented into policies and 
practice in the delivery of care1. Studies show that as many as 30% of patients do not 
receive acute care of proven effectiveness, and this can rise to 40% for chronic care. 
Moreover, as many as 30% of patients receive acute care that is unnecesary or 
potentially harmful2. Much recent empirical research has focused on strategies to 
translate research evidence into clinical practice (www.rxforchange.ca).   A systematic 
review of interventions to disseminate printed educational materials concluded that such 
interventions can be effective in improving process outcomes but not patient outcomes3.   
Examples of other promising methods include audit and feedback (especially when 
baseline compliance is low and feedback is delivered more intensively4), local opinion 
leaders (‘champions’5), and reminders6. The effects of any of these interventions 
considered separately are modest to moderate (10 to 15%). Combined (multifaceted) 
interventions aiming at acting on different barriers to change do not display a clear dose-
response relationship6, however, it is plausible that multifaceted interventions built upon 
a careful assessment of barriers may be more effective than single interventions7. 
 
Although most of this evidence is based on research in the care of adults, there has 
been one randomised controlled trial in neonatal care.   The Vermont Oxford Network 
conducted a cluster randomised controlled trial (CRCT), using a multifaceted 
collaborative quality improvement intervention (audit and feedback, lectures on reviews 
of the evidenced-based literature, an interactive training workshop and ongoing faculty 
support via conference calls and email) to promote evidence-based surfactant treatment 
for preterm babies born at 23−29 weeks’ gestation8.  This intervention was associated 
with a significant improvement (40%) in the earlier surfactant administration compared to 
usual dissemination strategies. 
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The Vermont Oxford trial, like most of the relevant literature, was based in North 
America.  The main aim of the present study is to use the rigour of a randomised 
controlled trial in an evaluation comparing the effects of different approaches to 
knowledge transfer on policy and practice in the care of preterm babies in another 
setting.   
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METHODS  
The methods are reported in the published trial protocol9. In summary, Project 27/2810 
conducted by the UK Confidential Enquiry into Maternal and Child Health (CEMACH) 
(now Centre for Maternal and Child Enquiries (CMACE)) provided the basis for this trial. 
Variations in standards of care were reported that may have contributed to the death of 
preterm babies born at 27 or 28 weeks’ gestational age. The results and a dissemination 
package with PowerPoint slides were distributed to all UK Neonatal Units.  To evaluate 
the impact on policy and practice of this dissemination, CEMACH sent a questionnaire to 
key UK recipients. Responses were received from 94 out of 262 neonatal/paediatric 
clinicians (36%), and 86 of the 183 acute hospitals with maternity services (47%). Three-
quarters of the respondents said they recalled receiving the dissemination package, and 
most reported using the slide package, finding it useful for raising awareness of the 
clinical issues and fostering the initiation and/or consolidation of policy and practice 
changes.  
 
However, gaps remained between the evidence and current practice. This led to a 
position statement on “Early Care of Premature Babies” from the British Association of 
Perinatal Medicine (BAPM)11. 
 
The aim of the BLISS cluster randomised controlled trial of the Effect of ‘Active 
Dissemination of Information’ on standards of care for premature babies in England 
(BEADI) trial was to assess whether an evidence-based innovative ‘active’ knowledge 
transfer strategy was more likely to lead to changes in policy and practice than the 
passive dissemination of the report, the slide package and the neonatal position 
statement on a website. 
 
A Acolet submitted_310111.doc 6
The intended effect was to change practice and policy at institutional level, therefore a 
CRCT where randomisation is by hospitals is the most appropriate design12, as this 
allows the delivery of the intervention to be focused on all staff.   
 
Participants 
There were three levels:  
1. Neonatal units: the 180 hospitals in England with neonatal intensive care units were 
identified at the beginning of 2006 by CEMACH working with the EPICure2 study 
group (http://www.epicure.ac.uk/epicure-2).   
2. Lead clinicians from the Neonatal units (see under Interventions below for further 
details about their roles) 
3. Babies born at <27 weeks’ gestation in England in January-March 2007, iidentified 
using the CEMACH (now CMACE) nationwide network for data collection13.   
 
Randomisation 
Neonatal Units were stratified by designation of level of care within the managed Clinical 
Neonatal Networks (n = 25) and by level of care delivered (level I, II or III), and then 
ordered alphabetically by name of hospital and imported into statistical computer 
software Stata 9 at LSHTM.  The programme generated a series of blocks of varying 
size (two, four, or six) for each stratum and allocated units to control or active 
intervention randomly within each block.   
 
Interventions 
1. Control arm: Clinicians in the control group had previously been sent the CEMACH 
Project 27/28 report which identified variations in standards of care that might have 
contributed to death in preterm babies born at 27 or 28 weeks gestation. In addition, 
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they were informed about recommendations and the position statement on early care 
of the newborn available on the British Association of Perinatal Medicine website10, 
and sent an accompanying slide set specifically tailored for different audiences to aid 
discussions at local hospital clinical governance meetings.  
2. Active arm (Box 1):  Clinicians in the active group received the same information but 
in addition were sent a letter explaining the BEADI study and asking them to 
volunteer to play one of the following roles: 
a. Regional ‘champions’ who would attend two workshops (Web Tables 1 & 2) 
and then provide ongoing support to clinicians within their Network in 
implementing the research evidence;  
b. Other Lead clinicians who would attend one workshop and work at 
implementing the research evidence in their own unit.  
The workshops used an organisational development cycle14 in which a 
theoretical approach recognises and uses participants’ experiential learning to
provide a framework to inform the practical process of planned change and to 
introduce other approaches to manage change. These approaches are enha
by practical hints, tips, and tools for local use.  Within this framework, se
nomination (volunteering) may enhance local communication and coordination, 
employee motivation and capability in the change process
 
nced 
lf-
15. 
 
A third group of clinicians in the active arm did not volunteer for either of these roles. 
 
Outcomes 
The main outcomes were at the level of Unit policy and practice chosen to meet the 
following criteria: (i) the outcomes needed to be important; (ii) there was an evidence 
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base for interventions to address these outcomes; and (iii) the outcomes were those 
collected in the EPICure2 study (see below).   
 
Project 27/28 showed that a delay in surfactant administration, hypothermia on 
admission, and inadequately experienced staff present at resuscitation at birth were 
strongly associated with death.  Hence BEADI focused on these three main areas of 
neonatal care.  The wording used to describe these outcomes was consolidated at the 
2nd workshop (see Box 2). 
 
Data collection 
 
The BEADI study collaborated with the EPICure2 study group and CEMACH to avoid 
duplicating data collection. Data about pre-intervention unit policies were collected by 
EPICure2 in early 2006.  No information about surfactant policies was available from 
EPICure2, nor about pre-intervention practices in time for the BEADI study.  Post-
intervention data about both policies and practice were collected by CEMACH for 
January-March 2007.   
  
Sample size 
The power calculations were based on a two-stage approach for policies (units) and for 
practice (babies).  Based on consultation with experts, we assumed pre-intervention 
rates of between 35% and 60% for the existence of policies for timing of surfactant 
administration, early temperature control and skill-mix of the resuscitation team.  Data 
from 130 of the 180 neonatal intensive care units were available from EPICure2.  This 
number would be sufficient to detect effect sizes (relative risks (RRs)) between 1.4 and 
1.6, with 80% power at 5% level of statistical significance (two-sided test).   
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The power calculations for practice outcomes were based on an estimated 1650 annual 
admissions for neonatal intensive care from 3,500 births of babies <27 weeks in 
England. Over a three month period, we therefore expected approximately 850 births 
and 400 admissions.  We used a range of likely intra-cluster correlation coefficient (ICC) 
from published databases of active dissemination research in previous trials, to estimate 
the power to detect differences in practice between the trial arms.  For example, 400 
admissions will have around 80% power to detect a difference in practices from 40% to 
55% (5% two-sided significance) with ICC of 0.06R.   
 
After completing the initial power calculations, further information became available via 
the EPICure2 study, and we were able to randomise 180 units. The power calculations 
were therefore conservative and allowed for losses to follow up.  
 
Statistical analysis 
Analysis was based on intention to treat principles, comparing outcomes from all the 
hospitals allocated to active intervention with those allocated to control.  For the policies, 
the analysis is based on hospitals.  Fisher’s exact test was used when the expected 
values in any cells were less than five.  Analysis for practice outcomes is based on 
babies within hospitals, taking appropriate account of the clustering by using the generic 
Stata survey command to estimate design-based F statistics to assess significance 
levels and estimating effects using generalised models with standard errors adjusted for 
inter-group correlation.  Subgroup analyses are based on the stratification factors.  
Exploratory per-protocol analyses compared outcomes from hospitals in the control arm 
to those in the active arm where a lead clinician attended one or more workshops. 
 
Ethical considerations 
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Approval for the study was granted by the Multi-centre Research Ethics Committee 
(MREC), and the East London and the City Local Research Ethics Committee (LREC). 
Consent for intervention was requested post-randomisation from the Lead clinicians (and 
their local RECs and Trust R&D departments) for units allocated to the active 
intervention arm. With the agreement of the EPICure2 Steering Committee, MREC 
approval was also granted for the download of selected data items to CEMACH from the 
EPICure2 study. Data about babies were anonymised, but data about centres were 
coded in order to allow linkage with the CEMACH 2007 data collection, and individual 
centres were not named in any publications.  Although information about BEADI had 
been posted on the BAPM website, clinicians in the control arm were only asked for their 
consent to the CEMACH data collection for BEADI towards the end of 2006 to reduce 
the likelihood of changes in their behaviour related to the study outcomes (a modified 
Zelen design)16.   
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RESULTS 
Eighty seven of the 180 units were randomised into the active arm, and 93 into the 
control arm.  Pre-intervention policy data were available from EPICure2 for 161 units (78 
active (89.7%) and 83 control (89.2%)).  The randomised groups were broadly 
comparable, and nearly all the units already had policies in place for prevention of 
hypothermia and for the resuscitation team at birth, before the trial began (Table 1).   
 
A request to participate was mailed to the 87 clinical leads in the active arm early in 
2006.  Eleven did not wish to participate, and the LREC or Trust R&D department 
refused permission for a further two units.  Representatives from 11 of the remaining 74 
units volunteered to act as regional champions and attended both workshops in 
September and October 2006. Representatives of a further 37 units attended the 2nd 
workshop only, and 26 did not attend either workshop.  No representatives from the 
control units were invited to or attended either workshop.   
 
At the 2nd workshop, the wording of the key ‘messages’ for the champions and Clinical 
leads to disseminate and support was discussed and provisionally agreed, with further 
refinements during email follow up over the ensuring weeks (Box 2).  
 
The costs of these workshops totalled £11,485 (consisting of the fees for the behavioural 
change experts, travel reimbursements, room hire and subsistence). 
 
Information about policies in January-March 2007 was available for 131 units (62 active 
(71.3%) and 69 control (74.2%)).  Although there was no scope for improvement in the 
percentage of units having a strategy for hypothermia prevention, the percentage where 
the strategy involved delivering the baby into a plastic bag or wrapping did increase 
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(albeit only marginally) from 89% to 95%, but there was no evidence of a difference 
between the trial arms (RR 0.98, 95%CI 0.90 to 1.07; p=0.71).  Similarly, the percentage 
where there was a policy about the paediatric staff present at the time of birth increased 
from 87% to 95%, but the difference between the trial arms, although not statistically 
significant, favoured the control arm (Table 2).  This reflected the pre-intervention 
differences between the groups and, based on the 110 units with information at both 
time points, 9/51 introduced this policy in the active group compared to 4/59 in the 
control group.   
 
Information about practice outcomes for January to March 2007 was available from 94 
units for 355 babies born between 22 and 26 weeks (169 from 45 units in the active arm, 
and 186 from 49 units in the control arm).  More of the babies in the control arm were 
male and their mean birth weight was lower than those in the active arm (Table 3).  A 
slightly higher proportion of missing data was from the level 2 units. Babies in the active 
arm were more likely to have been given surfactant on the labour ward (RR=1.30; 
95%CI 0.99-1.70); p=0.06); to have a higher temperature on admission to NICU (mean 
difference=0.29oC; 95%CI 0.22-0.55; p=0.03); to have had the trunk delivered in a 
plastic bag (RR=1.27; 95%CI 1.01-1.60; p=0.04) than those in the control. The effect on 
having an ‘ideal’ resuscitation team at birth was in the same direction of benefit for the 
active arm (OR=1.18; 95%CI 0.97-1.43) but did not reach conventional levels of 
statistical significance (p=0.09) (Table 4).  
 
Given the high percentage of hospitals adhering to the policies post intervention, it was 
not meaningful to undertake the formal planned subgroup analyses based on the 
stratification factors at policy level, or per-protocol analyses.   In terms of practice 
outcomes, pre-specified subgroup analyses did not find any interactions between arm of 
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the trial and level of care; however formal interaction tests were not undertaken between 
network and arm of the trial due to the high number of strata (25).  In per-protocol 
analyses, the effect on practice appeared similar or only very slightly higher in the 
groups in which at least one workshop was attended (78.5% surfactant on labour ward, 
79.1% delivery into plastic bag, 67.1% with ‘ideal team, and mean temperature 36.4 
compared to 78.3 %, 78.8%, 67.7% and 36.5 respectively). 
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DISCUSSION 
This cluster randomized trial is the first trial in neonatal medicine in England to evaluate 
methods for translating research into local policies and practice.  The catchment area 
was nationwide and the methods were rigorous.  Using an innovative ‘active’ knowledge 
transfer strategy led to significant changes in practice compared with passive 
dissemination of the research report, a slide package and a ‘position statement’ on a 
website.  The costs of the intervention (including workshop facilitators, travel, room hire 
and food) were modest. 
 
Limitations related to the lack of prior information about the extent to which the policy 
and practice outcomes were already in place. This meant that there was little scope for 
improving the policy outcomes (ceiling effects), and there was less power than planned 
for the practice outcomes.  In addition, a RCT about the use of occlusive plastic 
wrapping was in progress 
(http://clinicaltrials.gov/ct2/show/record/NCT00930917?term=occlusive+wrapping&rank=
1) 
 
Another potential limitation of the study was the extent of loss to follow up.  This was, 
however, equal in both trial arms and built into the power calculations.  Although it 
appears that a higher proportion of level 2 hospitals may have had missing data 
compared to levels 1 and 3, the numbers (20 missing hospitals) are too small to draw 
confident conclusions about implications for generalisability.   
 
There may have been some dilution of effects because even the control arm received 
information about Project 27/28 with a slide set for further dissemination.  Also, although 
clinicians in the control arm were not formally told about their BEADI allocation until late 
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2006 (de facto, blinded), it is possible they could have then changed their policies or 
practice, or amended data from their units in a biased way.  This seems unlikely.  The 
active intervention might have been more successful if representatives of more of the 
units attended either workshop.  The level of take up was in part a consequence of the 
decision to ask for consent only after randomisation (the modified Zelen design16).  This 
may have reduced power, but meant that the initial decision to participate in the study 
was not biased by knowledge of the allocation.    
 
The intervention might have been more effective if a more intensive approach was used.   
Although the BEADI team facilitated further contacts and support for the clinicians in the 
Active arm via email and telephone over the following 2-3 months, the intervention was 
less intensive than in the Vermont Oxford trial which used a tight network of clinicians 
who worked together and were receptive to quality improvement and benchmarking of 
their performance17.  In addition, the Vermont Oxford trial used a two-day interactive, 
collaborative improvement workshop ; social networking during the meeting (which has 
been shown to contribute to the success of collaborative initiatives); interactive 
networking with good communication between the main centre collecting evidence and 
detailing it proactively to the different hospitals in the network; and the use of the 
continuous quality improvement concept applied through the Rapid Cycle Improvement 
Process (RCIP)18. Two further quality improvement cluster randomised trials were 
published after the BEADI fieldwork, both also in North America and both using pre-
existing networks of clinicians.  One focused on benchmarking and did not find a 
significant effect on bronchopulmonary dysplasia (BPD) -free survival, although the study 
was confounded by an unexpectedly low rate of BPD in the pre-intervention year, 
making improvement more difficult19.  Lee et al20 randomised units to quality 
improvement strategies focusing on either reducing BPD or nosocomial infection.  There 
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was a clear benefit for reducing BPD, but not for reducing nosocomial infection (as this 
also improved in the non-nosocomial infection arm). 
The less intensive approach taken in BEADI, however, was more suited to the UK and 
similar settings where it can be seen as part of continuing professional development 
within the NHS.  The costs (including workshop facilitators, travel, room hire and food) 
were modest.  Recent progress in the role of the Managed Clinical Neonatal Networks, 
and greater use of internet communications, including conference calls, should be 
considered when developing this promising approach to translational medicine in the 
future.  
In conclusion, this active approach to research dissemination is both feasible and cost-
effective in the NHS.     
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Box 1: The intervention  
 
1. Workshop 1, September 2006 provided regional champions with time to explore: a) 
the theory and practice of NHS organisational change; b) the role of champions as 
leaders; c) behaviour change principles and the human dimension of changes and d) 
how to develop practical skills to effect and sustain change in order to support health 
care staff in their workplace. The attendees were supervised by trainers with 
expertise in organisational change. 
2. At workshop 2, a week later, the regional champions and trainers, were joined by 
consultants and senior nurses  from the ‘active’ units to explore: a) the research 
evidence in specified clinical areas (see Outcomes below) summarised in lectures 
from national clinical leaders; b) benchmarking of individual policies and practices 
and c) introduction to tools and practice of change. The clinical leads were then 
asked to determine actions to: a) develop responses to suggested areas of changes 
locally and b) the support and processes needed to achieve these changes. 
3. After the Workshops, the trial team distributed preliminary benchmarking information 
to allow participating units to see how practices in their own centres compared to 
practices in England overall.  The team also facilitated further contacts and support 
via email and telephone over the following 2-3 months. 
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Box 2: Practice Aims 
(As agreed at, and shortly after, the Workshops) 
 
 
1. All intubated babies (<27 weeks) should receive 
surfactant within an hour of birth (as early as 
compatible with safety) 
 
2. At all births <27 weeks gestational age, the 
following should be called and be present before 
the baby is delivered: A consultant paediatrician or 
a middle grade practitioner and a Senior House 
Officer  or an Advanced Neonatal Nurse 
Practitioner  
 
3. Core temperature on admission to NICU should be    
≥ 36°C (taken electronically)  
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Table 1:  Characteristics of units and pre-intervention policies 
 
 Random Allocation 
 Active Control 
All units  n=87 n=93 
Unit level 1 - n (%) 19 (21.8) 20 (21.5) 
Unit level 2 - n (%) 42 (48.3) 47 (50.5) 
Unit level 3 - n (%) 26 (29.9) 26 (28.0) 
   
   
Units with information available about pre-
intervention policies 
N=78 N=83 
Unit level 1 - n (%) 17 (21.8) 18 (21.7) 
Unit level 2 - n (%) 37 (47.4) 41 (49.4) 
Unit level 3 - n (%) 24 (30.8) 24 (28.9) 
No of admissions to neonatal unit in 2005* - median 
[IQR]  
302 [242,443] 309 [228,397] 
No of admissions to neonatal unit  for babies with 
birthweight < 1.5kg in 2005* - median [IQR] 
48.5 [30,8] 44 [24,68] 
Policy specifying which paediatric staff should be 
present at an extremely preterm birth - n (%) 
64/77 (83.1) 74/82 (90.2) 
Strategy for hypothermia prevention - n (%) 75 (96.2) 80 (96.4) 
Strategy for hypothermia prevention involving 
delivering the baby into a polythene bag n (%) 
67 (85.9) 77 (92.8) 
   
 
* or 2004 if 2005 data not available 
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 Table 2:  Policies post-intervention  
 
 Random Allocation RR  
(95%CI) 
P-
value 
 Active (n=87) Control (n=93)   
Information not available 25 24   
 N = 62  
n (%) 
N = 69  
n (%) 
  
Policy specifying which 
paediatric staff should be present 
at an extremely preterm birth  
55/61 (90.2) 67/68 (98.5) 0.92 
[0.84,0.99] 
0.052 
Strategy for hypothermia 
prevention 
61 (98.4) 67/68 (98.5) 1.00 
[0.96,1.04] 
1.00 
Strategy for hypothermia 
prevention involving delivering 
the baby into plastic bag or 
wrapping 
58 (93.6) 63/66 (95.5) 0.98 
[0.90,1.07] 
0.71 
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Table 3:  Characteristics of babies post-intervention 
 
 
 Active 
N=186 
Control 
N=169 
P value 
Sex male n (%) 93 (50.8) 104 (61.5) 0.05 
Birth weight (kg) - 
mean (SD)  
0.78 (0.01) 0.73 (0.01) 0.01 
Gestational age 
(weeks) - mean (SD) 
24.8 (0.09) 24.6 (0.10) 0.27 
Congenital anomaly 
- n (%) 
8 (4.3) 3 (1.8) 0.18 
Caesarean section – 
n (%) 
63 (33.9) 45 (26.6) 0.21 
No heartbeat @ birth 
- n (%) 
18 (9.7) 17 (10.1) 0.93 
Heart rate <100 @ 5 
mins - n (%) 
41 (22.0) 50 (29.6) 0.14 
 
Table 4:  Practices post-intervention 
 
 Random Allocation    
 Active  Control     
 N=169 babies N=186 babies RR  
(95% CI) 
Mean difference 
(95% CI) 
P value 
Surfactant given on labour ward - n (%) 141 (78.3) 96 (60.4)  1.30 
(0.99,1.70)
 0.06 
‘Ideal’ resuscitation team composition @ birth* - n (%) 126 (67.7) 97 (57.4)  1.18 
(0.97,1.43)
 0.09 
Temperature on admission to neonatal unit – mean (SD) 36.5 (0.08) 36.2 (0.08)  0.29 (0.02,0.55) 0.03 
Trunk delivered in a plastic bag to avoid hypothermia - 
n (%) 
141 (78.8) 93 (62.0) 1.27 
(1.01,1.60)
 0.04 
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What is already known on this topic 
• Translation of the clinical benefit of research evidence into policies and practice by 
traditional dissemination of information methods is very poor. 
• One North American neonatal trial showed that an intensive, complex (and expensive) 
approach significantly increased the evidence-based use of artificial surfactant in preterm 
babies. 
• No attempt has been made to rectify this gap in applying knowledge in the UK setting using 
more economical methods. 
What this study adds 
• A cluster randomized trial of UK neonatal units, using innovative ‘active’ knowledge transfer 
strategies, led to significant changes in practice compared with passive dissemination. 
• This is the first English trial to evaluate methods for transferring information from neonatal 
research into local polices and practice. The costs were modest. 
• This active approach to research dissemination is both feasible and cost-effective in the NHS.   
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